Participants of the current study were part of the prospective cross-sectional “PS-OCT Fiber Tracing Study.” Subjects were recruited from October 8, 2018, to March 6, 2020, at the Center of Medical Physics and Biomedical Engineering and the Department of Ophthalmology and Optometry of the Medical University of Vienna. The study was approved by the local ethics committee and followed the tenets of the Declaration of Helsinki. Written informed consent was obtained from all subjects before participation.
Inclusion criteria for the healthy subjects were (1) men and women aged between 18 and 79 years; (2) refractive error (spherical equivalent) of −5.0 diopters (D) to 5.0 D; (3) normal findings in medical history unless the investigator considered an abnormality to be clinically irrelevant; (4) normal ophthalmic findings, especially normal appearance of the ONH and normal VF. Inclusion criteria and definition of early glaucoma were (1) same as above, but with the glaucomatous appearance of the ONH and repeatedly abnormal 24-2 VF; (2) mean deviation (MD) of VF better than −6.0 dB.
In both groups, the following exclusion criteria were applied: (1) history of ocular trauma; (2) ocular surgery within the last three months before study inclusion; (3) evidence of any eye disease except refractive error unless the investigator considered an abnormality to be clinically irrelevant; (4) astigmatism of 2.0 D or worse; (5) history of hypersensitivity to tropicamide eye drops or similar substances; and (6) pregnancy and lactation.
In the present study, we collected data from 179 normal and 66 early glaucoma participants (one eye each) out of which we had to exclude 69 eyes for quality issues (image quality, corneal compensation, stitching), leaving datasets of 51 glaucoma patients and 125 healthy subjects. Because patients with diabetes mellitus showed alterations in RET and BIR in a recent study,
25 we excluded another two glaucoma and nine healthy subjects who had diabetes mellitus. Therefore the final dataset included 49 early glaucoma patients to whom we age-matched 49 healthy controls using SPSS case-control matching. To estimate the repeatability of the PS-OCT scans, three whole datasets were acquired on two different days in a subset of 12 glaucomatous and six healthy eyes.
The PS-OCT prototype used in this study was operating with a central wavelength of 860nm and a bandwidth of 60 nm with an A-scan rate of 70 kHz. An integrated scanning laser ophthalmoscope (SLO) was used for retinal tracking.
26,27 This study was part of a larger project aiming at wide-field RNF bundle tracing, which required the acquisition of stitched wide-field PS-OCT volume scans.
26 In all subjects, we thus recorded three volumes (28° × 21°), each at seven different retinal locations (21 volumes in total). Each volume scan consisted of 1024 times 250 A-scans. From these 21 volume scans, a wide-field PS-OCT image was stitched with a size covering at least 45° of the fundus,
26 which was then the basis for the extraction of a virtual annular B-scan centered on the optic disc with a diameter of 3.5 mm and a bandwidth (width of the annulus) of 0.1 mm. Within this given width of the circumpapillary evaluation band, 12 virtual concentric circles were calculated. For each circle, 2048 virtual A-scans were generated, each of which was a distance-weighted average of the adjacent real A-scans. Finally, our virtual circular B-scan was produced by averaging the virtual A-scans from the 12 virtual circles. For each A-scan of the final virtual circular B-scan, the averaged information from three to 12 volume scans (mostly between six to nine volumes, depending on the location of the A-scan in respect to the scanning pattern)
26 was used. Based on these virtual circular PS-OCT scans, we extracted our main outcome variables: BIR, RNFL-T, and phase retardation (RET). These parameters were evaluated globally and sector-wise for the temporal, superior, nasal, and inferior quadrants. The BIR of the RNFL was calculated at each virtual A-scan position as the quotient of the RET measured at the inner segment/outer segment junction and the corresponding RNFL-T. Large vessels, including vessel walls, were excluded from the virtual circular scans based on the position of vessel shadows on the retinal pigment epithelium in the averaged intensity scans using a dynamic threshold. Because our prototype PS-OCT machine had no standardized quality measure, all recorded images were checked for the correctness of corneal BIR compensation.
28 Images where the stitching algorithm failed or that showed poor-quality cornea compensation were excluded from the analysis. The segmentation of the virtual circular scans was checked for correctness and manually corrected if necessary.
The Humphrey Field Analyzer II with the SITA-Standard algorithm and stimulus size III was used for the 24-2 VF tests. Outcome parameters were VF MD and pattern standard deviation (PSD). Similar to what was described before, we determined the affected VF hemispheres.
29 The following criteria had to be met in the 24-2 VF tests to determine whether a VF hemisphere was considered affected: at least three contiguous points on the pattern deviation probability plot with sensitivity reduced to
P < 0.05, including at least one point at
P < 0.01 on two consecutive VF tests no more than two weeks apart.
Statistical analyses were performed using SPSS Version 21. Global and sector-wise means including 95% confidence intervals (95% CI) of the virtual circular B-scan parameters, as well as age, eye length, intraocular pressure, cup-to-disc ratio, VF 24-2 MD, and VF 24-2 PSD were compared between healthy and glaucoma subjects using the t-test for independent samples. A χ2 test was used to compare frequencies of sex between healthy and glaucoma. Receiver operating characteristics were calculated to compare the diagnostic accuracy of our main outcome variables. Repeatability was tested by calculating intraclass correlation coefficients and pooled standard deviation of RNFL-T, RET, and BIR. P values < 0.05 were considered statistically significant.